Table VI.

Summary of Toxicity Profile of NPS Hallucinogen Drug Subclasses

Organ system	PCP-like analogues	Ketamine analogues	Phenethylamine analogues
CNS	Delusions, confusion, aggression, psychomotor agitation, altered or fluctuating consciousness	Agitation, aggression, abnormal behavior, hallucination, delusions, impaired consciousness, loss of consciousness, unstable emotions, psychotic symptoms and unsteady gait	Agitation, aggression, seizures, euphoria, hallucinations and loss of consciousness
Cardiovascular	Tachycardia and hypertension	Tachycardia, hypertension and palpitations	Tachycardia, hypertension and cardiac arrest
Pulmonary	Tachypnea, respiratory acidosis	Dyspnea	Respiratory distress, heavy breathing and apnea
Other	Hypothermia, mydriasis, excessive sweating and vertical nystagmus	Hyperthermia, rhabdomyolysis, nystagmus, drowsiness, dizziness, convulsion, nausea, vomiting and self-harm	Hyperthermia, mydriasis, rhabdomyolysis, sweating, salivation, tremors and serotonin syndrome
Postmortem findings	Edema and congestion of lungs, brain and heart	Brain swelling and lung hyperhydration	Edema and congestion of lungs and brain